Security National Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Security National Bank’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-400	Closed	-$285K	–	326
2024 Q4	$285K	Hold	400	–	–	0.04%	99
2024 Q3	$420K	Hold	400	–	–	0.06%	88
2024 Q2	$420K	Hold	400	–	–	0.06%	86
2024 Q1	$385K	Hold	400	–	–	0.06%	89
2023 Q4	$351K	Hold	400	–	–	0.08%	89
2023 Q3	$334K	Hold	400	–	–	0.09%	83
2023 Q2	$287K	Buy	400 +90	+29%	+$69.4K	0.07%	89
2023 Q1	$255K	Hold	310	–	–	0.07%	88
2022 Q4	$224K	Sell	310 -40	-11%	-$29.5K	0.06%	95
2022 Q3	$241K	Buy	+350	New	+$220K	0.07%	87

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Security National Bank's REGN Position: Q1 2025 in Review

Security National Bank sold out of Regeneron Pharmaceuticals (REGN) in Q1 2025, closing a stake of 400 shares — an estimated $285K sold.

Security National Bank first reported a position in REGN in Q3 2022 and held it in 10 quarters. The position peaked at $420K in Q3 2024. 1,293 funds tracked by Wall St. Rank hold REGN as of Q1 2025.

Security National Bank reported no remaining Regeneron Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Security National Bank sold 400 Regeneron Pharmaceuticals shares in Q1 2025, an estimated $285K.
Security National Bank first reported a position in Regeneron Pharmaceuticals in Q3 2022 and held it in 10 quarters.
Security National Bank's Regeneron Pharmaceuticals position peaked at $420K in Q3 2024.
1,293 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2025.

Based on Security National Bank's 13F filing for Q1 2025, filed 23 Apr 2025.